Login

Lori Woods, CEO of Isoray, Inc. 00:00:00

Share On Facebook Share On Twitter

Isoray Discusses CEO Transition, Vision for the Company and Value Catalysts Moving Forward

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Apple's Ecosystem Focus and Antitrust Concerns Amidst iPhone 11 Cycle
00:10:00
Cristóbal Silva Discusses Destácame's Capital Raise and Entrepreneurship Challenges with Co-Founder Jorge Camus | LarrainVial Asset Management
00:10:00
Driving Hypergrowth in GreenTech: Insights from Laurits Bach Sørensen of Nordic Alpha Partners | Laurits Bach Sørensen - Partner, Nordic Alpha Partners
00:10:00
Monarch Capital Institute: Shaping Future Finance Leaders
00:10:00
The Council are a operator focused group of female angel investors|Amber Illig,Founding General Partner,The Council Fund
00:10:00
Theta Edge Berhad wins the Software - IT Services category at the Malaysia Technology Excellence Awards 2023.
00:10:00
Essential Tips on Determining Your Capital Contribution to Your Company: Expert Insights from Katherine Taylor of Taylor Legal
00:10:00
Professionals aiming to provide the financing required to develop the space economy|Raphael Roettgen,Founder and Managing Partner,E2MC Ventures
00:10:00
Basil Karampelas discusses ClearVue Technologies Ltd.'s vision and progress in an interview with The Market Herald.
00:10:00
December 2022 Market Update: Economic Data, Yield Curves, and Investment Insights
00:10:00
Estate Planning Essentials: Understanding the Clayton Election
00:10:00
We're a team of former serial founders managing over $1.25B across a number of funds|Avi Eyal,Cofounder And Managing Partner, Entrée Capital

© 2017 - Neuhu+